Reoperation Rates for Recurrent Ovarian Endometriomas after Surgical Excision

M S Ahmed, Shafeeq Ahmed, R L Barbieri, Robert L. Barbieri
Gynecologic and obstetric investigation · 2010 · vol. 43(1) , pp. 53–54 · doi:10.1159/000291819 · PMID:9015701 · W2038811637
article OA: bronze CC0 ⤵ 9 in-corpus citations
📄 Open PDF View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

A retrospective analysis of 104 women undergoing surgical excision for ovarian endometriomas found a reoperation rate of 2.9% for recurrence, with a peak recurrence probability of 7% at 32 months.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

This was a retrospective study analyzing the need for reoperation for recurrent endometriomas after surgical therapy. There were 104 women who were followed after surgical excision of endometriomas, with a cross section of 46 gynecologic surgeons. When using a life-table for follow-up analysis, only 2.9% of all patients had reoperation for recurrence, with a maximum recurrence probability of 7% at 32 months of follow-up.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Ovarian Cysts Adult Endometriosis Female Follow-Up Studies Humans Ovarian Cysts Recurrence Reoperation Reoperation Retreatment Retreatment Retrospective Studies Time Factors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (9)

Source provenance

europepmc
last seen: 2026-06-13T06:22:48.782012+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:10:57.821266+00:00
License: CC0 · commercial use OK